揭示口腔癌的分子蓝图:一种新的分类,以指导精确治疗
Manoj Pandey1, Pooja Singh2, Mridula Shukla3
1Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India; DHR-ICMR Advanced Molecular Oncology Diagnostic Services (DIAMOnDS), Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India; Health Technology Assessment India (HTAIn) Resource Center, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India.
Mutation research. Reviews in mutation research
|December 27, 2025
概括
这项研究提出了第一个口腔癌的分子分类,确定了五个关键的基因变异组. 这一框架有助于理解和开发针对口腔癌的向治疗方法.
科学领域:
- 基因组医学是基因组医学.
- 癌症基因组学 癌症基因组学
- 分子瘤学分子瘤学
背景情况:
- 口腔癌对健康造成重大负担,特别是在东南亚,发病率和死亡率很高.
- 现有的基因组研究尚未为口腔癌建立明确的分子分类.
- 了解分子异质性对于推进治疗策略至关重要.
研究的目的:
- 解决缺乏分子分类的问题,提出一种基于遗传变化的口腔癌新系统.
- 识别和分类涉及口腔癌发展的关键基因和途径.
- 为有针对性的治疗开发提供基础.
主要方法:
- 在PubMed上进行了全面的文献搜索,确定了8176篇关于口腔癌基因组学的文章.
- 选择了专注于基因组学的研究,并编制了一份涉及致癌的48个基因列表,与TCGA数据进行交叉引用.
- 利用集群分析,基因本体学和蛋白质-蛋白质相互作用网络来开发分类.
主要成果:
- 鉴定并将48个基因分类为五个主要的分子组:细胞循环失调,免疫介导,异生物代谢相关,炎症通路激活和病毒蛋白激活.
- 细胞循环失调,包括生长和亡变化,是最常见的途径 (~60%的病例),TP53是常见的变化.
- 突出显示了免疫介导和炎症途径的治疗潜力,同时指出外源生物和病毒途径仍未得到充分探索.
结论:
- 这项研究提出了口腔癌的第一个分子分类,定义了五个关键的致癌途径.
- 拟议的框架提高了对口腔癌分子多样性的理解.
- 预计这种分类将指导向疗法的开发,特别是对于未被充分研究的途径,如异生物代谢和炎症.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
What is Cancer?
13.9K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
13.9K


